Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertram Pitt

Showing results (271-280 of 688) with videos related to

Pageof 69
Sort By:
Lasers in Surgery and Medicine|July 16, 2011
Photothermolysis of sebaceous glands in human skin ex vivo with a 1,708 nm Raman fiber laser and contact coolingVinay V Alexander, Kevin Ke, Zhao Xu, et al.
JACC. Heart Failure|November 30, 2019
MRAs in Elderly HF Patients: Individual Patient-Data Meta-Analysis of RALES, EMPHASIS-HF, and TOPCATJoão Pedro Ferreira, Xavier Rossello, Romain Eschalier, et al.
European Heart Journal|May 29, 2013
Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trialBertram Pitt, Lars Kober, Piotr Ponikowski, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 30, 2017
Association of digitalis treatment with outcomes following myocardial infarction in patients with heart failure or evidence of left ventricular dysfunction: an analysis from the High-Risk Myocardial Infarction Database InitiativeStefano Coiro, Nicolas Girerd, Patrick Rossignol, et al.
Diabetes, Obesity & Metabolism|July 10, 2023
Effect of sotagliflozin on albuminuria in patients with type 2 diabetes and chronic kidney diseaseDavid Z I Cherney, Deepak L Bhatt, Michael Szarek, et al.
European Journal of Heart Failure|May 8, 2012
Rationale and design of ARTS: a randomized, double-blind study of BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney diseaseBertram Pitt, Gerasimos Filippatos, Mihai Gheorghiade, et al.
The American Journal of Cardiology|April 11, 2018
Relation of High Serum Bilirubin to Short-Term Mortality Following a Myocardial Infarction Complicated by Left Ventricular Systolic Dysfunction (from the High-Risk Myocardial Infarction Database Initiative)Zied Frikha, João Pedro Ferreira, Erwan Bozec, et al.
Circulation. Heart Failure|August 14, 2013
Race influences the safety and efficacy of spironolactone in severe heart failureOrly Vardeny, Larisa H Cavallari, Brian Claggett, et al.
Hypertension (Dallas, Tex. : 1979)|May 10, 2021
Effect of KBP-5074 on Blood Pressure in Advanced Chronic Kidney Disease: Results of the BLOCK-CKD StudyGeorge Bakris, Pablo E Pergola, Belkis Delgado, et al.
The American Journal of Cardiology|April 16, 2013
Comparison of benazepril plus amlodipine or hydrochlorothiazide in high-risk patients with hypertension and coronary artery diseaseGeorge Bakris, Alexandros Briasoulis, Bjorn Dahlof, et al.
Pageof 69

Showing results (271-280 of 688) with videos related to

Sort By:
Pageof 69
Lasers in Surgery and Medicine|July 16, 2011
Photothermolysis of sebaceous glands in human skin ex vivo with a 1,708 nm Raman fiber laser and contact coolingVinay V Alexander, Kevin Ke, Zhao Xu, et al.
JACC. Heart Failure|November 30, 2019
MRAs in Elderly HF Patients: Individual Patient-Data Meta-Analysis of RALES, EMPHASIS-HF, and TOPCATJoão Pedro Ferreira, Xavier Rossello, Romain Eschalier, et al.
European Heart Journal|May 29, 2013
Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trialBertram Pitt, Lars Kober, Piotr Ponikowski, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 30, 2017
Association of digitalis treatment with outcomes following myocardial infarction in patients with heart failure or evidence of left ventricular dysfunction: an analysis from the High-Risk Myocardial Infarction Database InitiativeStefano Coiro, Nicolas Girerd, Patrick Rossignol, et al.
Diabetes, Obesity & Metabolism|July 10, 2023
Effect of sotagliflozin on albuminuria in patients with type 2 diabetes and chronic kidney diseaseDavid Z I Cherney, Deepak L Bhatt, Michael Szarek, et al.
European Journal of Heart Failure|May 8, 2012
Rationale and design of ARTS: a randomized, double-blind study of BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney diseaseBertram Pitt, Gerasimos Filippatos, Mihai Gheorghiade, et al.
The American Journal of Cardiology|April 11, 2018
Relation of High Serum Bilirubin to Short-Term Mortality Following a Myocardial Infarction Complicated by Left Ventricular Systolic Dysfunction (from the High-Risk Myocardial Infarction Database Initiative)Zied Frikha, João Pedro Ferreira, Erwan Bozec, et al.
Circulation. Heart Failure|August 14, 2013
Race influences the safety and efficacy of spironolactone in severe heart failureOrly Vardeny, Larisa H Cavallari, Brian Claggett, et al.
Hypertension (Dallas, Tex. : 1979)|May 10, 2021
Effect of KBP-5074 on Blood Pressure in Advanced Chronic Kidney Disease: Results of the BLOCK-CKD StudyGeorge Bakris, Pablo E Pergola, Belkis Delgado, et al.
The American Journal of Cardiology|April 16, 2013
Comparison of benazepril plus amlodipine or hydrochlorothiazide in high-risk patients with hypertension and coronary artery diseaseGeorge Bakris, Alexandros Briasoulis, Bjorn Dahlof, et al.
Pageof 69